Disposition of 16151 shares by Blank Burkhard of MannKind Corp at 4.78 subject to Rule 16b-3 Filed transaction by MannKind Corp Officer: Evp Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Disposition of 16151 shares by Blank Burkhard of MannKind Corp at 4.78 subject to Rule 16b-3

MNKD Stock  USD 4.12  0.05  1.23%   
About 56% of all MannKind Corp's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding MannKind Corp suggests that some traders are interested. The current market sentiment, together with MannKind Corp's historical and current headlines, can help investors time the market. In addition, many technical investors use MannKind Corp stock news signals to limit their universe of possible portfolio assets.
Filed transaction by MannKind Corp Officer: Evp Chief Medical Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 16151 common stock, $0.01 par value at 4.78 of MannKind Corp by Blank Burkhard on 24th of May 2024. This event was filed by MannKind Corp with SEC on 2024-05-24. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

MannKind Corp's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the MannKind Corp's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

MannKind Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards MannKind Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

MannKind Corp Historical Investor Sentiment

Investor biases related to MannKind Corp's public news can be used to forecast risks associated with an investment in MannKind. The trend in average sentiment can be used to explain how an investor holding MannKind can time the market purely based on public headlines and social activities around MannKind Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
MannKind Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for MannKind Corp and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average MannKind Corp news discussions. The higher the estimate score, the more favorable the investor's outlook on MannKind Corp.

MannKind Corp Fundamental Analysis

We analyze MannKind Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MannKind Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MannKind Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Liabilities

Current Liabilities Comparative Analysis

MannKind Corp is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

MannKind Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MannKind Corp stock to make a market-neutral strategy. Peer analysis of MannKind Corp could also be used in its relative valuation, which is a method of valuing MannKind Corp by comparing valuation metrics with similar companies.

Peers

MannKind Corp Related Equities

LRMRLarimar Therapeutics   15.58   
0%
100.0%
LQDALiquidia Technologies   5.78   
0%
37.0%
KTTAPasithea Therapeutics   4.44   
0%
28.0%
ELEVElevation Oncology   3.33   
0%
21.0%
SGMOSangamo Therapeutics   2.22   
0%
14.0%
VSTMVerastem   2.10   
0%
13.0%
IMMPImmutep   2.07   
0%
13.0%
SABSSAB Biotherapeutics   1.69   
0%
10.0%
ADAPAdaptimmune Therapeutics   1.11   
0%
7.0%
TECHBio Techne   0.83   
0%
5.0%
BMRNBiomarin Pharmaceutical   0.79   
0%
5.0%
LEGNLegend Biotech   0.73   
0%
4.0%
DAWNDay One   0.16   
0%
1.0%
KNSAKiniksa Pharmaceuticals   0.29   
1.0%
0%
INKTMink Therapeutics   5.49   
35.0%
0%

Complementary Tools for MannKind Stock analysis

When running MannKind Corp's price analysis, check to measure MannKind Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MannKind Corp is operating at the current time. Most of MannKind Corp's value examination focuses on studying past and present price action to predict the probability of MannKind Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MannKind Corp's price. Additionally, you may evaluate how the addition of MannKind Corp to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.